WE DID IT!

Currently, Medicare and most major insurances does not cover lymphedema supplies including lymphedema bandaging and lymphedema compression garment. These supplies were crucial to reduce and maintain the low level of swelling caused by lymphedema. Lymphedema Treatment Act is a federal law passed on 12/23/22 that will go into effect on 1/1/24 to improve insurance coverage for medically necessary lymphedema compression supplies. Starting next year, lymphedema supplies will be covered by most insurance.

Special thanks to Lymphedema Advocacy Group, Heather Ferguson, Sarah Bramblette, the rest of the team.

I am looking for information about:

Are you at Risk

Take Action Against Lymphedema

The early stages (stage 0 and stage 1) of lymphedema are often reversible. Therefore, early prevention, detection, and treatment are crucial. This is very important to see our healthcare provider as soon as you notice any types of swelling.

In this video, Chloe Peyton OTR/L, medical director at RoM Edema Center, will share the importance of early detection of lymphedema.

We are here to help

Applying for Assistance:

  1. Complete the Application Form

  2. Provide Proof of Income (1 of the following)

    W-2, 1099 or Schedule C

    Letter from employer stating pay

    Copy of most recent bank statement

  3. A letter from your doctor verifying your current diagnosis and detailling treatment plan

Questions about qualifications or the application process? Email us at inquiries@lymphnode.org

News and Stories

Giacomo Mongagna, MD conducted research on the relationship between race and ethnic disparities in patients with breast cancer-related lymphedema. They discovered that the 24-month lymphedema rate was 23.8% for patients with breast cancer. Black race and Hispanic ethnicity had the greatest association with lymphedema development. There is no significant relationship between old age or longer followup and lymphedema incident rate.

Brandon Dixon, Professor in the George W. Woodruff School of Mechanical Engineering, have developed a new treatment using nanoparticles that can repair lymphatic vessel pumping. The researcheers are expanding the formulation to more advanced disease models to move it closer to human application. Hopefully, the technology can treat or prevent lymphedema.

Vanderbilt University School of Nursing Professor Sheila Ridner, PhD, FAAN, recently completed a large randomized trial to assess early detection methods and early intervention for lymphedema. The result of this five-year, multi-site trial to assess lymphedema prevention was released.

The Godoy & Godoy method has showed to enable the near normalization of lymphedema in all clinical stages, including elephantiasis stage. The clinical trial for clinical stage II primary lymphedema has seen 40% to 70% reduction in limb volume.

There is a new case presentation of primary lymphedema in Children. The case is special because it is not secondary to Turner syndrome or Noonan Syndrome, but an isolated lymphedema case.

Daniel Greene, PHD from Icahn School of Medicine at Mount Sinai was able to identify the genetic causes of primary lymphedema.